dcgi
dcgi
Drugs Controller Rejects Bharat Biotech's Request for Covid Vaccine Trials on Kids, Seeks Efficacy Data First
Dr Reddy's Begins Process for Emergency Use Authorisation of Russian Covid-19 Vaccine Sputnik V
Seven More States to Administer Covaxin from Next Week, Says Health Ministry
Covid-19: Dr Reddy's Gets DCGI Nod to Conduct Phase 3 Clinical Trials for Sputnik V Vaccine
Covaxin vs Covishield: Is Bharat Biotech’s COVID-19 Vaccine Being Unfairly Singled Out?
Coronavirus News HIGHLIGHTS: Govt Readies Deal for 6.6 Crore Vaccine Doses With Serum Institute, to Cost Rs 200 Per Jab
Zydus Cadila Gets DCGI Nod to Initiate Phase-3 Clinical Trials for Covid-19 Vaccine
News18 Afternoon Digest: India Formally Approves Oxford-AstraZeneca, Bharat Biotech Vaccines & Other Top Stories
Hyderabad-based Bharat Biotech Recruits 23,000 Volunteers for Phase III Trials of Covaxin
Oxford Covid-19 Vaccine May Become First to Get Indian Regulator DCGI's Nod for Emergency Use
Gennova Biopharmaceuticals Granted Conditional Permission for Human Clinical Trial of Its COVID-19 Vaccine
Coronavirus News LIVE Updates: Drug Controller Likely to Make Decision on Emergency Use of Pfizer, AstraZeneca’s Vaccines in 2 Weeks
Bharat Biotech Plans to Launch Vaccine Candidate in Second Quarter of 2021 after Nod from Regulator
Covid-19: DCGI Rejects Dr Reddy's Proposal Seeking Full Marketing Authorisation of Remdesivir
Dr Reddy's Hopes to Finish Phase 3 Trials of Russian Covid-19 Vaccine by March-May
Dr Reddy's Reapplies to DCGI for Conducting Phases 2, 3 Clinical Trials of Russian Covid-19 Vaccine
DCGI Nod to Phase-1 Human Trials of 'Antisera' with Potential to Treat Covid-19
All You Need To Know About Feluda - India's First Paper-Strip COVID-19 Test
Drug Body Approves Commercial Launch of Low Cost Covid-19 Test 'Feluda'
Serum Institute Gets Approval to Resume India Trial of AstraZeneca Covid-19 Vaccine: Source
